Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Eur J Med Chem ; 252: 115304, 2023 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-37001390

RESUMEN

A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1-3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 µM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo.


Asunto(s)
Antineoplásicos , Naftoquinonas , Humanos , Animales , Ratones , Tiazoles/química , Antineoplásicos/química , Naftoquinonas/farmacología , Doxorrubicina/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Estructura Molecular , Simulación del Acoplamiento Molecular , Relación Estructura-Actividad , Proliferación Celular , Línea Celular Tumoral
2.
Int J Mol Sci ; 23(21)2022 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-36361924

RESUMEN

Oncological diseases have currently reached an epidemic scale, especially in industrialized countries. Such a situation has prompted complex studies in medicinal chemistry focused on the research and development of novel effective anticancer drugs. In this review, the data concerning new 4-thiazolidinone-bearing hybrid molecules with potential anticancer activity reported during the period from the years 2017-2022 are summarized. The main emphasis is on the application of molecular hybridization methodologies and strategies in the design of small molecules as anticancer agents. Based on the analyzed data, it was observed that the main directions in this field are the hybridization of scaffolds, the hybrid-pharmacophore approach, and the analogue-based drug design of 4-thiazolidinone cores with early approved drugs, natural compounds, and privileged heterocyclic scaffolds. The mentioned design approaches are effective tools/sources for the generation of hit/lead compounds with anticancer activity and will be relevant to future studies.


Asunto(s)
Antineoplásicos , Diseño de Fármacos , Tiazolidinas/farmacología , Tiazolidinas/química , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Antineoplásicos/química , Química Farmacéutica
3.
Pharmaceutics ; 14(11)2022 Oct 25.
Artículo en Inglés | MEDLINE | ID: mdl-36365105

RESUMEN

Nanomedicine is a potential provider of novel therapeutic and diagnostic routes of treatment. Considering the development of multidrug resistance in pathogenic bacteria and the commonness of cancer, novel approaches are being sought for the safe and efficient synthesis of new nanoparticles, which have multifaceted applications in medicine. Unfortunately, the chemical synthesis of nanoparticles raises justified environmental concerns. A significant problem in their widespread use is also the toxicity of compounds that maintain nanoparticle stability, which significantly limits their clinical use. An opportunity for their more extensive application is the utilization of plants, fungi, and bacteria for nanoparticle biosynthesis. Extracts from natural sources can reduce metal ions in nanoparticles and stabilize them with non-toxic extract components.

4.
Int J Mol Sci ; 23(12)2022 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-35743130

RESUMEN

Several authorities have implied that nanotechnology has a significant future in the development of advanced cancer therapies. Nanotechnology makes it possible to simultaneously administer drug combinations and engage the immune system to fight cancer. Nanoparticles can locate metastases in different organs and deliver medications to them. Using them allows for the effective reduction of tumors with minimal toxicity to healthy tissue. Transition-metal nanoparticles, through Fenton-type or Haber-Weiss-type reactions, generate reactive oxygen species. Through oxidative stress, the particles induce cell death via different pathways. The main limitation of the particles is their toxicity. Certain factors can control toxicity, such as route of administration, size, aggregation state, surface functionalization, or oxidation state. In this review, we attempt to discuss the effects and toxicity of transition-metal nanoparticles.


Asunto(s)
Nanopartículas del Metal , Nanopartículas , Neoplasias , Elementos de Transición , Nanopartículas del Metal/uso terapéutico , Nanotecnología , Neoplasias/tratamiento farmacológico , Oxidación-Reducción , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo , Elementos de Transición/farmacología
5.
Int J Mol Sci ; 22(15)2021 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-34361037

RESUMEN

There is a need for new, safer, and more effective agents to treat cancer. Cytostatics that have transition metals at their core have attracted renewed interest from scientists. Researchers are attempting to use chemotherapeutics, such as cisplatin, in combination therapy (i.e., in order to enhance their effectiveness). Moreover, studies are being carried out to modify molecules, by developing them into multinuclear structures, linking different compounds to commonly used drugs, or encapsulating them in nanoparticles to improve pharmacokinetic parameters, and increase the selectivity of these drugs. Therefore, we attempted to organize recent drug findings that contain palladium and platinum atoms in their structures.


Asunto(s)
Antineoplásicos/química , Neoplasias/tratamiento farmacológico , Compuestos Organoplatinos/química , Paladio/química , Animales , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Ensayos Clínicos como Asunto , Sinergismo Farmacológico , Humanos , Compuestos Organoplatinos/farmacología , Compuestos Organoplatinos/uso terapéutico
6.
Opt Express ; 29(12): 18122-18138, 2021 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-34154078

RESUMEN

We present a direct comparison between two types of femtosecond 2 µm sources used for seeding of an ultrafast thulium-doped fiber amplifier based on all-normal dispersion supercontinuum and soliton self-frequency shift. Both nonlinear effects were generated in microstructured silica fibers, pumped with low-power femtosecond pulses at 1.56 µm originating from an erbium-doped fiber laser. We performed a full characterization of both nonlinear processes, including their shot-to-shot stability, phase coherence, and relative intensity noise. The results revealed that the solitons show comparable performance to supercontinuum in terms of relative intensity noise and shot-to-shot stability, despite the anomalous dispersion regime. Both sources can be successfully used as seeds for Tm-doped fiber amplifiers as an alternative to Tm-doped oscillators. The results show that the sign of chromatic dispersion of the fiber is not crucial for obtaining a stable, high-quality, and low-noise spectral conversion process when pumped with sub-50 fs laser pulses.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...